Commentary: Can Kicking and Rip Currents
In a cohort of 314 young adults with congenital heart disease (ACHD) who underwent bioprosthetic aortic valve replacement (b-AVR), Fuller et al. report surgical valve reintervention in 11% of patients at a median follow-up of 2.5 years and an actuarial survival of only 85% at 5 years.1 Young age, smaller valve, and one particular type of valve were associated with shorter time to reintervention – not too surprising.2 Apparently, echocardiographic discharge data was available for only approximately half the cohort.
Source: Seminars in Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Authors: Ronald K. Woods Tags: CONGENITAL – Commentary Source Type: research
More News: Cardiology | Cardiovascular | Cardiovascular & Thoracic Surgery | Heart | Heart Disease | Heart Valve Surgery